Peak Bio Inc's Comment on Sales, Marketing and Customers
Peak Bio is a clinical-stage biopharmaceutical company developing therapeutics for cancer, inflammatory, and rare diseases. The company collaborates with researchers, clinicians, patient advocacy groups, academic institutions, governmental agencies, and investors. Its current focus is on the proprietary Peak Bio R&D Discovery Toxin and ADC Platform Engine. The management team has experience in drug development, including small molecules, antibodies, and antibody-drug conjugates (ADCs). Customers and partners mentioned in company filings include Abbott, BiPar Sciences, BridgeBio, CytomX Therapeutics, Epizyme, Facet Biotech, Geron Corporation, McKinsey & Co, Nektar Therapeutics, pH Pharma, Pliant Therapeutics, and Sanofi.
Peak Bio Inc’s Comment on Sales, Marketing and Customers
Peak Bio is a clinical-stage biopharmaceutical company developing therapeutics for cancer, inflammatory, and rare diseases. The company collaborates with researchers, clinicians, patient advocacy groups, academic institutions, governmental agencies, and investors. Its current focus is on the proprietary Peak Bio R&D Discovery Toxin and ADC Platform Engine. The management team has experience in drug development, including small molecules, antibodies, and antibody-drug conjugates (ADCs). Customers and partners mentioned in company filings include Abbott, BiPar Sciences, BridgeBio, CytomX Therapeutics, Epizyme, Facet Biotech, Geron Corporation, McKinsey & Co, Nektar Therapeutics, pH Pharma, Pliant Therapeutics, and Sanofi.
Sources:
Peak Bio Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Peak Bio Inc’s corporate clients.
For your research, we’ve provided 9 tables on Peak Bio Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
